Aytu BioPharma, Inc. (AYTU)
1.99
+0.02
(+1.02%)
USD |
NASDAQ |
Oct 13, 16:00
2.00
+0.01
(+0.50%)
After-Hours: 20:00
Aytu BioPharma EPS Diluted (Quarterly) : -0.0008 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0008 |
| March 31, 2026 | -0.5345 |
| December 31, 2025 | -1.055 |
| September 30, 2025 | -0.0773 |
| June 30, 2025 | -2.918 |
| March 31, 2025 | 0.2112 |
| December 31, 2024 | -0.2626 |
| September 30, 2024 | 0.162 |
| June 30, 2024 | -0.8216 |
| March 31, 2024 | -0.5217 |
| December 31, 2023 | -0.0399 |
| September 30, 2023 | -1.481 |
| June 30, 2023 | -0.5929 |
| March 31, 2023 | -1.932 |
| December 31, 2022 | -43.04 |
| September 30, 2022 | -5.568 |
| June 30, 2022 | -178.91 |
| March 31, 2022 | -35.75 |
| December 31, 2021 | -8.744 |
| September 30, 2021 | -21.76 |
| June 30, 2021 | -16.15 |
| March 31, 2021 | -28.14 |
| December 31, 2020 | -14.34 |
| September 30, 2020 | -7.082 |
| June 30, 2020 | -5.548 |
| Date | Value |
|---|---|
| March 31, 2020 | -30.23 |
| December 31, 2019 | -2.444 |
| September 30, 2019 | -64.32 |
| June 30, 2019 | -165.72 |
| March 31, 2019 | -99.24 |
| December 31, 2018 | -143.82 |
| September 30, 2018 | -391.68 |
| June 30, 2018 | 61.00 |
| March 31, 2018 | -19013.84 |
| December 31, 2017 | -3560.00 |
| September 30, 2017 | -7040.00 |
| June 30, 2017 | -16640.00 |
| March 31, 2017 | -38400.00 |
| December 31, 2016 | -48800.00 |
| September 30, 2016 | -93600.00 |
| June 30, 2016 | -407184.0 |
| March 31, 2016 | -374400.0 |
| December 31, 2015 | -220800.0 |
| September 30, 2015 | -153600.0 |
| March 31, 2015 | -467481.6 |
| February 28, 2015 | -19751.10 |
| November 30, 2014 | -32022.49 |
| August 31, 2014 | -22789.73 |
| May 31, 2014 | -26997.06 |
| February 28, 2014 | -52708.55 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
| Eli Lilly & Co. | 7.939 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.015M |
| Revenue (Quarterly) | 16.11M |
| Total Expenses (Quarterly) | 16.12M |
| Enterprise Value | 13.15M |
| Gross Profit Margin (Quarterly) | 59.90% |
| Profit Margin (Quarterly) | -0.09% |
| Earnings Yield | -83.78% |
| Normalized Earnings Yield | -83.77 |